Pedram Heidari, MD
Chief of Nuclear Medicine and Molecular Imaging
Assistant Professor of Radiology
About Epitorix
Driven by biology.Powered by AI.
Computational infrastructure for high-stakes pharma
Who we are
Epitorix designs radiopharmaceuticals with its own models, offers the products built on them, and runs its own programs.
Epitorix is an AI radiopharmaceutical company. It builds its own models, the products on them — a modular design workspace and two de-risking reports — and the drug programs that put both to the test: four AI-designed radiopharmaceutical programs, now being tested in vivo. Every figure on this site carries its basis; a preprint describing the evaluation is forthcoming.
Our mission
To make the highest-stakes decisions in radiopharmaceutical development earlier, so the right candidates reach patients sooner.
Our vision
Drug development run as engineering: the reasons a candidate would fail, predicted before a trial rather than discovered in one.
How we work
The models first, then the bench.
Team
Founder-led
Babak Saboury, MD, MPH
Physician-Scientist, Radiologist & Nuclear Medicine Physician
Co-Founder & Chief Innovation Officer, United Theranostics
Epitorix's pipeline programs are investigational and preclinical. No Epitorix product has been approved by the FDA, the EMA or any other regulator, and no clinical safety or efficacy has been established.
Contact
Bring us a target.
A target to design against, a candidate to de-risk, or the pipeline data.
Laboratory bench · liquid handler and assay plates